Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
14
Purchases
0
Sales
14
Purchase value
$0.00
Sale value
$2.58M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Scott M. GiacobelloCHIEF FINANCIAL OFFICER
4
Filed Apr 17, 2026Period of report Apr 15, 20260001754154-26-000010
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleApr 16, 2026
Common StockF1
141,600
$4.13
$584.81K
295,224
Direct
SaleApr 15, 2026
Common StockF1F2
77,000
$3.86
$297.22K
436,824
Direct
Filing footnotes · 2
F1Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F2Includes an aggregate of 11,822 shares of Common Stock acquired between November 14, 2022 and November 15, 2025 under the Issuer's 2021 Employee Stock Purchase Plan.
Filed Apr 15, 2026Period of report Apr 13, 20260001766522-26-000011
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleApr 14, 2026
Common StockF1
92,460
$3.64
$336.55K
397,106
Direct
SaleApr 13, 2026
Common StockF1
26,389
$3.46
$91.31K
489,566
Direct
Filing footnotes · 1
F1Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
Filed Apr 13, 2026Period of report Apr 9, 20260001766522-26-000009
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleApr 10, 2026
Common StockF1
6,596
$3.43
$22.62K
515,955
Direct
SaleApr 9, 2026
Common StockF1
50,000
$3.57
$178.50K
522,551
Direct
Filing footnotes · 1
F1Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
David James LennonDirector · CHIEF EXECUTIVE OFFICER
4
Filed Apr 10, 2026Period of report Apr 9, 20260001995275-26-000012
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleApr 9, 2026
Common StockF1
14,500
$3.38
$49.01K
518,622
Direct
Filing footnotes · 1
F1Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
David James LennonDirector · CHIEF EXECUTIVE OFFICER
4
Filed Apr 8, 2026Period of report Apr 6, 20260001995275-26-000008
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleApr 8, 2026
Common StockF1
63,945
$3.40
$217.41K
533,122
Direct
SaleApr 7, 2026
Common StockF1
94,087
$3.43
$322.72K
597,067
Direct
SaleApr 6, 2026
Common StockF1
102,395
$3.51
$359.41K
691,154
Direct
Filing footnotes · 1
F1Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
David James LennonDirector · CHIEF EXECUTIVE OFFICER
4
Filed Apr 3, 2026Period of report Apr 1, 20260001995275-26-000006
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleApr 2, 2026
Common StockF2
26,858
$3.48
$93.47K
793,549
Direct
Filing footnotes · 4
F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
F2Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F3Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2025.
F4Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2026.
David James LennonDirector · CHIEF EXECUTIVE OFFICER
4
Filed Mar 10, 2026Period of report Mar 1, 20260001995275-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF2
5,100
$3.3096
$16.88K
44,579
Direct
Filing footnotes · 3
F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
F2Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F3Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.
Filed Mar 10, 2026Period of report Mar 1, 20260001766522-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF2
1,834
$3.3096
$6.07K
206,019
Direct
Filing footnotes · 3
F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
F2Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F3Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.
Filed Mar 10, 2026Period of report Mar 1, 20260001754154-26-000002
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF2
2,594
$3.3096
$8.59K
28,100
Direct
Filing footnotes · 3
F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
F2Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F3Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.